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Background
Because of anatomic proximity, myocarditis is often
associated with pericarditis. Although randomized trials
have not delineated a successful evidence-based therapy
for myocarditis, there is evidence of considerable benefit
in treating pericarditis with a regimen of colchicine and
a non-steroidal anti-inflammatory drug (NSAID). Car-
diac MRI (CMR) is capable of detecting both myocardi-
tis and pericarditis using T2 weighted pulse sequences
and delayed enhancement imaging with gadolinium.
This study was designed to assess the effect of a colchi-
cine/NSAID treatment regimen for myocarditis identi-
fied by CMR.
Methods
An institutional CMR database was queried for all patients
with pericarditis who had associated myocarditis. Those
patients with at least 1 follow-up CMR study to assess
response to therapy with a colchicine/NSAID regimen
constituted the study population. The follow-up CMR stu-
dies were categorized and tabulated as resolved, partially
resolved or no improvement with respect to myocarditis,
based on consensus of 2 experienced CMR interpreters.
Results
Forty-eight patients in the database were found to have
myocarditis/myo-pericarditis by CMR and at least 1
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Figure 1 Myocarditis response to colchicine therapy.
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follow-up CMR study. Twenty-seven of these patients
received colchicine and 17(63%) showed complete resolu-
tion of myocarditis on their last CMR study. Of the 21
patients who did not receive colchicine, only 8(38%) had
resolution of myocarditis by CMR study.
Conclusions
Randomized trials for treatment of myocarditis were done
prior to the availability of CMR imaging for this diagnosis,
and were mainly comprised of severe cases presenting as
heart failure. Myocarditis appears more readily diagnosed
with CMR, especially in its less fulminant presentations.
This study suggests that myocarditis, documented by
CMR, is responsive to colchicine, with rates of successful
therapy similar to those of published reports of colchicine
for pericarditis. These data also suggest that CMR imaging
should be considered in any future randomized trials of
myocarditis therapy, including colchicine.
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